Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Polarityte Inc (NQ: PTE )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 15, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Polarityte Inc

< Previous 1 2 3 4 5 6 Next >
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Trevena (NASDAQ:TRVN) shares moved upwards by 13.3% to $0.23 during Friday's after-market session. The market value of their outstanding shares is at $38.0 million. As per the news, the Q1... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Is SoFi (SOFI) Stock Up 20% Today?
SoFi (SOFI) stock is riding higher on Friday as the company's shares are recovering from a fall earlier this week and we know why! 
Via InvestorPlace
PTE Stock Soars 70% Following PolarityTE’s New FDA Designation
PolarityTE (PTE) stock is rocketing higher on Friday thanks to positive news from the U.S. Food and Drug Administration (FDA). 
Via InvestorPlace
Earnings Outlook For PolarityTE
PolarityTE (NASDAQ:PTE) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that PolarityTE will... 
Via Benzinga
Recap: PolarityTE Q4 Earnings
  PolarityTE (NASDAQ:PTE) reported its Q4 earnings results on Wednesday, March 30, 2022 at 07:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
PolarityTE Shares Jump After FDA Regenerative Medicine Advanced Therapy Designation (RMAT) for SkinTE
The U.S. Food and Drug Administration (FDA) has granted a Regenerative Medicine Advanced Therapy (RMAT) designation to PolarityTE’s (NASDAQ: PTE) SkinTE under the its open investigational new drug... 
Via Benzinga
The Daily Biotech Pulse: FDA Orphan Drug Tags For Neurocrine, Editas Candidates; Sale of BridgeBio's PRV; RMAT Designation For PolarityTE's Product
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Rise and shine, trader! Join me today as we break down all the news behind the biggest pre-market stock movers for Wednesday! 
Via InvestorPlace
Why Is PolarityTE Stock Up 85% Today?
PolarityTE Inc (NASDAQ: PTE) shares are surging Tuesday as traders circle bullish commentary from a popular trader in the "FinTwit" community. 
Via Benzinga
Biotech Stocks News: What’s Going on With LIXT, PTE, QLGN and ATNM Stocks Today?
Biotech stocks are up today amid an influx of positive news. Here's what investors need to know as these small companies skyrocket. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Good morning! It's time for another dive into the market this morning with a look at the biggest pre-market stock movers for Tuesday! 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 92 companies hit new 52-week lows. Areas of Interest About Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week... 
Via Benzinga
Looking Into PolarityTE's Return On Capital Employed
Benzinga Pro data, PolarityTE (NASDAQ:PTE) reported Q4 sales of $1.04 million. Earnings fell to a loss of $8.57 million, resulting in a 739.18% decrease from last quarter. 
Via Benzinga
Earnings Scheduled For March 30, 2022
Companies Reporting Before The Bell • Orgenesis (NASDAQ:ORGS) is likely to report earnings for its fourth quarter. • RumbleON (NASDAQ:RMBL) is estimated to report earnings for its Fiscal Year 2021. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 81 stocks hit new 52-week lows. Noteworthy Points From Today's 52-Week Lows: Grupo Aval Acciones (NYSE:AVAL) was the biggest company by market cap to set a... 
Via Benzinga
Earnings Preview: PolarityTE
PolarityTE (NASDAQ:PTE) is set to give its latest quarterly earnings report on Wednesday, 2022-03-30. Here's what investors need to know before the announcement. Analysts estimate that PolarityTE will... 
Via Benzinga
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Rise and shine, trader! We're starting off the day with a breakdown of the biggest pre-market stock movers for Wednesday! 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Corbus Pharmaceuticals (NASDAQ:CRBP) shares increased by 20.3% to $0.4 during Monday's pre-market session. The market value of their outstanding shares is at $49.7 million. 
Via Benzinga
PolarityTE Q4 2021 Earnings Conference Call On March 30, 2022 At 08:30 AM ET
PolarityTE (NASDAQ:PTE) will host a conference call at 08:30 AM ET on March 30, 2022, to discuss Q4 2021 earnings results. How to Attend PolarityTE (PTE) Conference Call Follow... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Sonnet BioTherapeutics (NASDAQ:SONN) stock rose 85.6% to $0.51 during Wednesday's pre-market session. The company's market cap stands at $30.8 million.... 
Via Benzinga
PolarityTE's SkinTE Meets Primary, Secondary Goals In Venous Leg Ulcers Trial
PolarityTE Inc (NASDAQ: PTE) has announced results from a multi-center randomized controlled trial evaluating SkinTE for Venous Leg Ulcers (VLU). There were twenty-... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Passage Bio (NASDAQ:PASG) shares moved upwards by 15.5% to $3.95 during Tuesday's pre-market session. The company's market cap stands at $213.3 million.... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Agile Therapeutics (NASDAQ:AGRX) ... 
Via Benzinga
PolarityTE, Inc. (NASDAQ:PTE) Long Term Investor Alert: Investigation over Possible Wrongdoing
San Diego, CA -- (SBWIRE) -- 01/26/2022 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of PolarityTE, Inc.. 
Via SBWire
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Mustang Bio (NASDAQ:MBIO) shares ... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.